Boehringer Ingelheim

For Healthcare Professionals

Contact Us

Malaysia | EN
Australia | EN
Korea | KR
New Zealand | EN
Philippines | EN
Singapore | EN
Thailand | EN
Vietnam | VN

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Products
- Malaysia | EN
- Australia | EN
- Korea | KR
- New Zealand | EN
- Philippines | EN
- Singapore | EN
- Thailand | EN
- Vietnam | VN
Malaysia | EN
Contact Us

Malaysia | EN
Australia | EN
Korea | KR
New Zealand | EN
Philippines | EN
Singapore | EN
Thailand | EN
Vietnam | VN

Boehringer Ingelheim

All Specialties
Cardiology
Nephrology
Endocrinology
Primary Care
Prescribing Information

Is the initial eGFR dip a cause for concern?

Featuring
Professor Christiane Angermann | Germany
Professor Ricardo Carvalho | Portugal

Home
All Specialties
Shorts
Is the initial eGFR dip a cause for concern?

Related content

Document ID: PC-MY-103755

Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)

Clinical relationship between the heart and the kidneys

Watch now Opens in new tab

Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)

Why is empagliflozin now a preferred heart failure treatment, coming from a history of diabetes?

Watch now Opens in new tab

Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)

How has recent evidence and the ESC 2023 guidelines changed management of heart failure?

Watch now Opens in new tab

Heart Failure 360: Early protection for every heart failure patient

Read more Opens in new tab

02:13:04

PRIME Summit 2 : Post event video day 1

Watch now Opens in new tab

BI logo

Accessibility Statement
Terms of Use
Sitemap
Privacy Policy

Products discussed herein may have different labeling in different countries. Use of this site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Notice.

© 2010-2025 Boehringer Ingelheim GmbH All rights reserved

Did you find what you were looking for?

Yes

No

Your feedback submitted Successfully !

Leave this field blank